EAM
RMD icon

EverPoint Asset Management’s ResMed RMD Stock Holding History

EverPoint Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-400,000
Closed -$23.1M – 503
2016
Q1 		$23.1M Buy
+400,000
New +$22.6M 0.45% 44
2015
Q1 		– Sell
-350,000
Closed -$19.6M – 577
2014
Q4 		$19.6M Buy
+350,000
New +$18.3M 0.44% 70

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

EverPoint Asset Management's RMD Position: Q2 2016 in Review

EverPoint Asset Management sold out of ResMed (RMD) in Q2 2016, closing a stake of 400,000 shares — an estimated $23.1M sold.

EverPoint Asset Management first reported a position in RMD in Q4 2014 and held it in 2 quarters. The position peaked at $23.1M in Q1 2016. 361 funds tracked by Wall St. Rank hold RMD as of Q2 2016.

  • EverPoint Asset Management reported no remaining ResMed position as of Q2 2016 after selling out during the quarter.
  • EverPoint Asset Management sold 400,000 ResMed shares in Q2 2016, an estimated $23.1M.
  • EverPoint Asset Management first reported a position in ResMed in Q4 2014 and held it in 2 quarters.
  • EverPoint Asset Management's ResMed position peaked at $23.1M in Q1 2016.
  • 361 funds tracked by Wall St. Rank held ResMed as of Q2 2016.

Based on EverPoint Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.